Europe Acute Ishemic Stroke Epidemiology and Patient Flow Analysis - 2017
Fore Pharma announced the results of its Acute Ishemic Stroke patients study in a new report ‘Europe Acute Ishemic Stroke Epidemiology and Patient Flow Analysis - 2017’. The report provides insights into Acute Ishemic Stroke epidemiology, Acute Ishemic Stroke diagnosed patients, and Acute Ishemic Stroke treatment rate for EU5 pharmaceutical markets. The study measures key indicators such as prevalence of Acute Ishemic Stroke derived from epidemiological analysis, percentage of patients diagnosed with Acute Ishemic Stroke, and percentage of patients treated with a therapy.
The study helps executives estimate Acute Ishemic Stroke market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.
The report provides estimates and forecasts of Acute Ishemic Stroke prevalence, Acute Ishemic Stroke diagnosis rate, and Acute Ishemic Stroke treatment rate for the period 2016 - 2025. The information is presented by leading geographies including Germany, France, Spain, Italy, and UK. The study design is based on interpretation and analysis of data collected from physicians via primary interviews, registries, scientific journals, literatures, government databases and other secondary sources.